In a major escalation of the patent battle over a life-saving rare disease drug, Swiss pharmaceutical giant F. Hoffmann-La ...
As more people start to opt for genetic carrier testing ahead of conception, doctors and parents-to-be are facing difficult ...
Gene therapy is linked to better nonmotor outcomes in spinal muscular atrophy type 1 compared to first-line nusinersen, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback